Multiple myeloma begins when abnormal cells multiply and grow uncontrollably in a person’s bone marrow, crowding out healthy ...

A team of doctors at Michigan Medicine have successfully treated a child in severe septic shock and multiorgan failure with ...

During a live event, Mojtaba Akhtari, MD, discussed the goals and treatment approach for patients with low-risk polycythemia ...

Panelists discuss how to approach a 67-year-old man with advanced polycythemia vera who is resistant to hydroxyurea, ...

PRF injections harness the power of your own fluids.

CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes ...

Bristol-Myers Squibb Company (NYSE:BMY) is one of the best stocks to buy for beginners now. On June 12, Bristol Myers Squibb shared new data from its targeted protein degradation platform at the 2025 ...

Panelists report that the AUGMENT-101 trial demonstrated meaningful clinical benefits of menin inhibitors in ...

The purge of probationary federal workers included skilled lab personnel who would have finalized a customized cell immunotherapy for cancer patients.

In a summer of increased need for blood donations, the American Red Cross hosted its first Pride in Every Drop drive to help ...

A novel assay will allow clinicians to analyze neonatal immune status in real-time using a single drop of blood, according to ...

Incyte's INCA033989 showed early efficacy and strong tolerability in essential thrombocythemia patients with mutCALR, supporting further development.